The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor

類似資料

• Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
  著者:: Mizoshita, Tsutomu, 等
  出版事項: (2017)
• Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis
  著者:: Tanida, Satoshi, 等
  出版事項: (2015)
• Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus
  著者:: Mizoshita, Tsutomu, 等
  出版事項: (2013)
• Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2
  著者:: Tanida, Satoshi, 等
  出版事項: (2015)
• The First Case of Biological Therapy Discontinuation After a Complete Remission Induced by Maintenance Therapy With Adalimumab for Refractory Ulcerative Colitis
  著者:: Tanida, Satoshi, 等
  出版事項: (2015)